Since we only had around 20 patients recruited by end 2021, there's little chance of demonstrating overwhelming efficacy before enrolment is completed as @GH1971 pointed out (2 year efficacy readouts).
Regardless, clearly the trial is not designed poorly and is safe.
CYP Price at posting:
35.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)